-
381
The impact of TRIPS Agreement on access to medicines in developing countries: Legal challenges faced by the pharmaceutical industry particularly in India
Published 2012“…Some developing countries even utilised TRIPS fl exibilities in an aggressive manner to enforce their right to have access to medicines from other countries for the benefi t of their citizens.Further, TRIPs fl exibilities have helped developing countries to manufacture generic products to make it affordable to the people.This paper specifi cally examines the impact of the TRIPS Agreement on Indian generic pharmaceutical industry and the legal challenges faced by Indian pharmaceutical industry after the implementation of product patent regime effective from 1 January 2005.The Patent Amendment Act 2005(India) will be looked into especially on the controversy in respect of Section 3(d) of the Patent Amendment Act 2005(India) on the requirement of patentability.The new Section 92A of the Patent Amendment Act 2005(India) on the grounds to invoke compulsory licensing will be analysed to see whether Indian government has applied restrictive or broad approach, as compulsory licensing is certainly an important legal weapon for India to manufacture affordable generic medicines.The current challenges faced by India on data exclusivity provision often described as the TRIPS PLUS standard is impliedly stated in Article 39.3 of the TRIPS Agreement on undisclosed information.India needs to achieve legal certainty in complying with the TRIPS Agreement and also bearing in mind the TRIPS-PLUS standards before adopting those TRIPS provisions into its patent law legislation in order to promote innovation and to achieve public health as well as to serve the interest of the developing countries…”
Get full text
Article -
382
-
383
-
384
Quality systems and control for pharmaceuticals /
Published 2008Subjects: “…Pharmaceutical industry…”
-
385
-
386
FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics /
Published 2008Subjects: -
387
-
388
-
389
-
390
-
391
The Structure of Trade in Genetic Resources: Implications for the International ABS Regime Negotiation
Published 2010-06-01Subjects: Get full text
Article -
392
Utilization of IT in Pakistan and MNC Pharma. Companies in the Korangi Industrial Area
Published 2006-01-01Subjects: Get full text
Article -
393
Activated pharmaceutical ingredients produced by microreactors versus batch processes: A review
Published 2022-11-01Subjects: Get full text
Article -
394
Transaction Costs and Organizational Competences: Explaining the Governance Structure for Manufacturing Stage
Published 2012-03-01Subjects: Get full text
Article -
395
CONTINUOUS PROFESSIONAL DEVELOPMENT OF PERSONNEL FOR THE PHARMACEUTICAL SECTOR
Published 2012-02-01Subjects: “…pharmaceutical industry…”
Get full text
Article -
396
Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market
Published 2015-09-01Subjects: Get full text
Article -
397
SIMULACIÓN DE UNA CADENA SE SUMINISTR O EN EL ÁREA FARMACÉUTICA
Published 2007-01-01Subjects: Get full text
Article -
398
Analisis Determinan Persepsi Masyarakat di Lingkungan Sekitar Industri Farmasi PT.X Kota Palembang
Published 2019-05-01Subjects: Get full text
Article -
399
EXPERIENCE OF CREATING BIOPHARMACEUTICAL CLUSTERS ABROAD AND IN RUSSIAN FEDERATION REGIONS AND ITS APPLYING FOR DEVELOPMENT OF PHARMACEUTICAL SECTOR OF TATARSTAN REPUBLIC
Published 2012-09-01Subjects: “…pharmaceutical industry…”
Get full text
Article -
400
TOO MUCH DRUG ADVERTISING? A QUALITATIVE PERSPECTIVE OF ROMANIAN PHARMACEUTICAL MARKET
Published 2018-07-01Subjects: “…promotional activity, ethics, pharmaceutical industry, advertisements…”
Get full text
Article